[1]
|
Sung, H., Ferlay, J., Siegel, R.L., et al. (2021) Global Cancer Statistics 2020: GLOBOCAN Estimates of Incidence and Mortality Worldwide for 36 Cancers in 185 Countries. CA: A Cancer Journal for Clinicians, 71, 209-249.
https://doi.org/10.3322/caac.21660
|
[2]
|
Zhang, Q., Tang, L., Zhou, Y., He, W.B. and Li, W.M. (2021) Immune Checkpoint Inhibitor-Associated Pneumonitis in Non-Small Cell Lung Cancer: Current Understanding in Characteristics, Diagnosis, and Management. Frontiers in Immunology, 12, Article 663986. https://doi.org/10.3389/fimmu.2021.663986
|
[3]
|
Bodor, J.N., Boumber, Y. and Borghaei, H. (2020) Biomarkers for Immune Checkpoint Inhibition in Non-Small Cell Lung Cancer (NSCLC). Cancer, 126, 260-270. https://doi.org/10.1002/cncr.32468
|
[4]
|
Schabath, M.B. and Cote, M.L. (2019) Cancer Progress and Priorities: Lung Cancer. Cancer Epidemiology Biomarkers & Prevention, 28, 1563-1579. https://doi.org/10.1158/1055-9965.EPI-19-0221
|
[5]
|
Yuan, M., Huang, L.L., Chen, J.H., Wu, J. and Xu, Q. (2019) The Emerging Treatment Landscape of Targeted Therapy in Non-Small-Cell Lung Cancer. Signal Transduction and Targeted Therapy, 4, Article No. 61.
https://doi.org/10.1038/s41392-019-0099-9
|
[6]
|
Shokoohi, A., Al-Hashami, Z., Moore, S., et al. (2022) Effect of Targeted Therapy and Immunotherapy on Advanced Nonsmall-Cell Lung Cancer Outcomes in the Real World. Cancer Medicine, 11, 86-93.
https://doi.org/10.1002/cam4.4427
|
[7]
|
Xiang, Y., Guo, Z., Zhu, P., Chen, J. and Huang, Y.Y. (2019) Traditional Chinese Medicine as a Cancer Treatment: Modern Perspectives of Ancient but Advanced Science. Cancer Medicine, 8, 1958-1975.
https://doi.org/10.1002/cam4.2108
|
[8]
|
Zhang, L., Zhang, F.Y. and Li, G.F. (2021) Traditional Chinese Medicine and Lung Cancer—From Theory to Practice. Biomedicine & Pharmacotherapy, 137, Article ID: 111381. https://doi.org/10.1016/j.biopha.2021.111381
|
[9]
|
全建峰, 任革, 白小娜, 等. 中晚期非小细胞肺癌中医证型研究[J]. 河北中医药学报, 2016, 31(4): 11-14.
|
[10]
|
王文越, 王新蒙, 许丹丹, 等. 黄芪-当归药对配伍效用及其影响因素研究概况[J]. 中国中医基础医学杂志, 2023, 29(5): 865-870.
|
[11]
|
袁伟琛, 甄建华, 李晓红. 黄芪抗肿瘤作用的研究现状[J]. 中华中医药学刊, 2023, 41(6): 91-97.
|
[12]
|
马燕, 张育贵,石露萍, 等. 当归炮制品及其化学成分和药理作用研究进展[J]. 中国中药杂志: 1-10.
https://doi.org/10.19540/j.cnki.cjcmm.20230717.301, 2023-07-19.
|
[13]
|
王雪振, 张小雨, 牟悦, 等. 当归补血汤在恶性肿瘤中作用的研究进展[J]. 中国实验方剂学杂志, 2022, 28(9): 214-220.
|
[14]
|
Zhou, Z., Chen, B., Chen, S., et al. (2020) Applications of Network Pharmacology in Traditional Chinese Medicine Research. Evidence-Based Complementary and Alternative Medicine, 2020, Article ID: 1646905.
https://doi.org/10.1155/2020/1646905
|
[15]
|
Guo, Q., Mao, X., Zhang, Y., et al. (2016) Guizhi-Shaoyao-Zhimu Decoction Attenuates Rheumatoid Arthritis Partially by Reversing Inflammation-Immune System Imbalance. Journal of Translational Medicine, 14, Article No. 165.
https://doi.org/10.1186/s12967-016-0921-x
|
[16]
|
Wu, X.M. and Wu, C.F. (2015) Network Pharmacology: A New Approach to Unveiling Traditional Chinese Medicine. Chinese Journal of Natural Medicines, 13, 1-2. https://doi.org/10.1016/S1875-5364(15)60001-2
|
[17]
|
Ru, J., Li, P., Wang, J., et al. (2014) TCMSP: A Database of Systems Pharmacology for Drug Discovery from Herbal Medicines. Journal of Cheminformatics, 6, Article No. 13. https://doi.org/10.1186/1758-2946-6-13
|
[18]
|
李亚男, 荣小凤, 曹文富, 等. 黄芪抗肿瘤有效成分及作用机制研究进展[J]. 实用中医药杂志, 2017, 33(3): 341-343.
|
[19]
|
王常明, 姜睿斌, 李锋. 当归化学成分及抗肿瘤作用机制的研究进展[J]. 癌变∙畸变∙突变, 2019, 31(2): 162-165.
|
[20]
|
徐婷, 麦葭沂, 向俊, 等. “黄芪-当归”药对主要活性成分的网络药理学研究[J]. 中药材, 2017, 40(9): 2195-2201.
|
[21]
|
Otasek, D., Morris, J.H., Bouças, J., Pico, A.R. and Demchak, B. (2019) Cytoscape Automation: Empowering Workflow- Based Network Analysis. Genome Biology, 20, Article No. 185. https://doi.org/10.1186/s13059-019-1758-4
|
[22]
|
Szklarczyk, D., Morris, J.H., Cook, H., et al. (2017) The STRING Database in 2017: Quality-Controlled Protein-Protein Association Networks, Made Broadly Accessible. Nucleic Acids Research, 45, D362-D368.
https://doi.org/10.1093/nar/gkw937
|
[23]
|
Chin, C.H., Chen, S.H., Wu, H.H., et al. (2014) cytoHubba: Identifying Hub Objects and Sub-Networks from Complex Interactome. BMC Systems Biology, 8, Article No. S11. https://doi.org/10.1186/1752-0509-8-S4-S11
|
[24]
|
Zhou, Y., Zhou, B., Pache, L., et al. (2019) Metascape Provides a Biologist-Oriented Resource for the Analysis of Systems-Level Datasets. Nature Communications, 10, Article No. 1523. https://doi.org/10.1038/s41467-019-09234-6
|
[25]
|
Herbst, R.S., Morgensztern, D. and Boshoff, C. (2018) The Biology and Management of Non-Small Cell Lung Cancer. Nature, 553, 446-454. https://doi.org/10.1038/nature25183
|
[26]
|
唐于平, 束晓云, 李伟霞, 等. 药对研究(Ⅰ)——药对的形成与发展[J]. 中国中药杂志, 2013, 38(24): 4185-4190.
|
[27]
|
Wu, T.H., Yeh, K.Y., Wang, C.H., et al. (2019) The Combination of Astragalus membranaceus and Angelica sinensis Inhibits Lung Cancer and Cachexia through Its Immunomodulatory Function. Journal of Oncology, 2019, Article ID: 9206951. https://doi.org/10.1155/2019/9206951
|
[28]
|
Rather, R.A. and Bhagat, M. (2020) Quercetin as an Innovative Therapeutic Tool for Cancer Chemoprevention: Molecular Mechanisms and Implications in Human Health. Cancer Medicine, 9, 9181-9192.
https://doi.org/10.1002/cam4.1411
|
[29]
|
Klimaszewska-Wiśniewska, A., Hałas-Wiśniewska, M., et al. (2017) Antiproliferative and Antimetastatic Action of Quercetin on A549 Non-Small Cell Lung Cancer Cells through Its Effect on the Cytoskeleton. Acta Histochemica, 119, 99-112. https://doi.org/10.1016/j.acthis.2016.11.003
|
[30]
|
Lee, S.H., Lee, E.J., Min, K.H., et al. (2015) Quercetin Enhances Chemosensitivity to Gemcitabine in Lung Cancer Cells by Inhibiting Heat Shock Protein 70 Expression. Clinical Lung Cancer, 16, E235-E243.
https://doi.org/10.1016/j.cllc.2015.05.006
|
[31]
|
Guo, H., Ding, H., Tang, X., et al. (2021) Quercetin Induces Pro-Apoptotic Autophagy via SIRT1/AMPK Signaling Pathway in Human Lung Cancer Cell Lines A549 and H1299 in vitro. Thoracic Cancer, 12, 1415-1422.
https://doi.org/10.1111/1759-7714.13925
|
[32]
|
Lee, H.J., Lee, H.J., Lee, E.O., et al. (2009) In vivo Anti-Cancer Activity of Korean Angelica gigas and Its Major Pyranocoumarin Decursin. The American Journal of Chinese Medicine, 37, 127-142.
https://doi.org/10.1142/S0192415X09006722
|
[33]
|
Chang, S.N., Khan, I., Kim, C.G., et al. (2021) Decursinol Angelate Arrest Melanoma Cell Proliferation by Initiating Cell Death and Tumor Shrinkage via Induction of Apoptosis. International Journal of Molecular Sciences, 22, Article 4096. https://doi.org/10.3390/ijms22084096
|
[34]
|
Chang, S.N. and Kang, S.C. (2023) Decursinol Angelate Inhibits Glutamate Dehydrogenase 1 Activity and Induces Intrinsic Apoptosis in MDR-CRC Cells. Cancers, 15, Article 3541. https://doi.org/10.3390/cancers15143541
|
[35]
|
Jung, S.Y., Choi, J.H., Kwon, S.M., et al. (2012) Decursin Inhibits Vasculogenesis in Early Tumor Progression by Suppression of Endothelial Progenitor Cell Differentiation and Function. Journal of Cellular Biochemistry, 113, 1478-1487.
https://doi.org/10.1002/jcb.24085
|
[36]
|
Choi, H.S., Cho, S.G., Kim, M.K., et al. (2016) Decursin in Angelica gigas Nakai (AGN) Enhances Doxorubicin Chemosensitivity in NCI/ADR-RES Ovarian Cancer Cells via Inhibition of P-Glycoprotein Expression. Phytotherapy Research, 30, 2020-2026. https://doi.org/10.1002/ptr.5708
|
[37]
|
Tošić, I. and Frank, D.A. (2021) STAT3 as a Mediator of Oncogenic Cellular Metabolism: Pathogenic and Therapeutic Implications. Neoplasia, 23, 1167-1178. https://doi.org/10.1016/j.neo.2021.10.003
|
[38]
|
Zou, S., Tong, Q., Liu, B., et al. (2020) Targeting STAT3 in Cancer Immunotherapy. Molecular Cancer, 19, Article 145. https://doi.org/10.1186/s12943-020-01258-7
|
[39]
|
Yu, H. and Jove, R. (2004) The STATs of Cancer—New Molecular Targets Come of Age. Nature Reviews Cancer, 4, 97-105. https://doi.org/10.1038/nrc1275
|
[40]
|
Zhang, J., Liu, X., Zhang, G., et al. (2023) To Explore the Effect of Kaempferol on Non-Small Cell Lung Cancer Based on Network Pharmacology and Molecular Docking. Frontiers in Pharmacology, 14, Article ID: 1148171.
https://doi.org/10.3389/fphar.2023.1148171
|
[41]
|
Zhou, J., Sun, M., Jin, S., et al. (2019) Combined Using of Paclitaxel and Salinomycin Active Targeting Nanostructured Lipid Carriers against Non-Small Cell Lung Cancer and Cancer Stem Cells. Drug Delivery, 26, 281-289.
https://doi.org/10.1080/10717544.2019.1580799
|
[42]
|
Wang, S., Liu, X., Zhou, T., et al. (2023) PKMYT1 Inhibits Lung Adenocarcinoma Progression by Abrogating AKT1 Activity. Cellular Oncology, 46, 195-209. https://doi.org/10.1007/s13402-022-00744-y
|
[43]
|
孙肖, 毕经旺. PI3K抑制剂与非小细胞性肺癌[J]. 中国肿瘤生物治疗杂志, 2017, 24(5): 547-552.
|
[44]
|
宋忠花, 张金庆, 王言森. PIK3CA基因对人非小细胞肺癌A549细胞侵袭及迁移能力的影响[J]. 解剖科学进展, 2018, 24(3): 293-295.
|
[45]
|
Pompura, S.L. and Dominguez-Villar, M. (2018) The PI3K/AKT Signaling Pathway in Regulatory T-Cell Development, Stability, and Function. Journal of Leukocyte Biology, 103, 1065-1076.
https://doi.org/10.1002/JLB.2MIR0817-349R
|
[46]
|
Zhang, M. and Zhang, X. (2019) The Role of PI3K/AKT/FOXO Signaling in Psoriasis. Archives of Dermatological Research, 311, 83-91. https://doi.org/10.1007/s00403-018-1879-8
|
[47]
|
Jiang, N., Dai, Q., Su, X., et al. (2020) Role of PI3K/AKT Pathway in Cancer: The Framework of Malignant Behavior. Molecular Biology Reports, 47, 4587-4629. https://doi.org/10.1007/s11033-020-05435-1
|
[48]
|
Xue, C., Yao, Q., Gu, X., et al. (2023) Evolving Cognition of the JAK-STAT Signaling Pathway: Autoimmune Disorders and Cancer. Signal Transduction and Targeted Therapy, 8, Article No. 204.
https://doi.org/10.1038/s41392-023-01468-7
|
[49]
|
Hu, X., Li, J., Fu, M., Zhao, X. and Wang, W. (2021) The JAK/STAT Signaling Pathway: From Bench to Clinic. Signal Transduction and Targeted Therapy, 6, Article No. 402. https://doi.org/10.1038/s41392-021-00791-1
|
[50]
|
Tzeng, H.T., Chyuan, I.T. and Lai, J.H. (2021) Targeting the JAK-STAT Pathway in Autoimmune Diseases and Cancers: A Focus on Molecular Mechanisms and Therapeutic Potential. Biochemical Pharmacology, 193, Article ID: 114760.
https://doi.org/10.1016/j.bcp.2021.114760
|
[51]
|
Villarino, A.V., Kanno, Y. and O’Shea, J.J. (2017) Mechanisms and Consequences of Jak-STAT Signaling in the Immune System. Nature Immunology, 18, 374-384. https://doi.org/10.1038/ni.3691
|